Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...

Beyond the pipeline, the exciting programs that we're advancing, we're also in these incredible partnerships working with Roche ... multi-timepoint brightfield images each week on our Phenomics ...

Donald Trump has criticised Ireland for using its tax policies to lure away US companies, as he threatened to escalate his ...

UK initiative to harness big biological data sets and look deeper into how the human body works and malfunctions ...

A sharply dressed queue of people lined up for red-carpet photos in front of a ... Genentech, owned by Roche, the world’s sixth-largest pharma company, kicked things off with a big win in ...